Cancer Research
Overview
Cancer Research is a renowned scientific journal dedicated to advancing our understanding of cancer biology, prevention, diagnosis, and treatment. It publishes cutting-edge research articles, reviews, and perspectives from leading experts worldwide, fostering collaboration and innovation in the fight against cancer.
Details
Details
Abbr.
Cancer Res
Start
1941
End
Continuing
Frequency
Semimonthly <, Jan. 1, 1987->
p-ISSN
0008-5472
e-ISSN
1538-7445
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 31
498
SJR / Ranks: 467
3468
CiteScore / Ranks: 502
16.90
JIF / Ranks: 377
11.2
Recent Articles
1.
Lim J, Jang G, Kang S, Lee G, Nga D, Phuong D, et al.
Cancer Res
. 2025 Mar;
85(6):1175.
PMID: 40083199
No abstract available.
2.
Wang Y, Meraz I, Qudratullah M, Kotagiri S, Han Y, Xi Y, et al.
Cancer Res
. 2025 Mar;
PMID: 40080526
Cancer genomic studies have identified frequent alterations in genes encoding components of the SWI/SNF chromatin remodeling complex, including SMARCA4 and ARID1A. Importantly, clinical reports indicate that SMARCA4-mutant lung cancers respond...
3.
Zhou M, Wu Z, Wei F, Duan C, Lin X, Zou W, et al.
Cancer Res
. 2025 Mar;
PMID: 40080525
The development of BCR-ABL tyrosine kinase inhibitors (TKIs) has revolutionized disease management of chronic myeloid leukemia (CML). However, the persistence of leukemia stem cells (LSCs) remains a major barrier to...
4.
Pedretti F, Abdalfttah M, Pellegrino B, Mateo F, Martinez-Sanz P, Herencia-Ropero A, et al.
Cancer Res
. 2025 Mar;
PMID: 40067927
Homologous recombination deficiency (HRD) contributes to genomic instability and leads to sensitivity to poly ADP-ribose polymerase inhibitors (PARPi). HRD also activates the cyclic GMP-AMP synthase (cGAS)-STimulator of INterferon Genes (STING)-Interferon...
5.
Orofino G, Toffalori C, Vago L
Cancer Res
. 2025 Mar;
PMID: 40067923
Donor Lymphocyte Infusion (DLI) is a crucial therapeutic strategy for relapsed myeloid malignancies post-allogeneic hematopoietic cell transplantation (allo-HCT), leveraging the graft-versus-leukemia (GvL) effect to restore immune control. While highly effective...
6.
Papargyriou A, Reichert M
Cancer Res
. 2025 Mar;
PMID: 40067920
Metastatic cancer remains a leading cause of cancer-related mortality, with a 5-year survival rate of just 8% for pancreatic ductal adenocarcinoma (PDAC). Among patients with metastatic PDAC, those with liver...
7.
Lawson-Michod K, Marks J, Collin L, Nix D, Davidson N, Huff C, et al.
Cancer Res
. 2025 Mar;
PMID: 40063699
Black individuals experience worse survival after a diagnosis of high-grade serous ovarian carcinoma (HGSC) than White individuals and are underrepresented in ovarian cancer research. To date, the understanding of the...
8.
Kong Y, Wang F, Jing R, Zhao Q, Lv X, Zhao Y, et al.
Cancer Res
. 2025 Mar;
PMID: 40053472
Diffuse intrinsic pontine gliomas (DIPGs) are lethal pediatric brain tumors that frequently harbor H3K27M mutations and lack effective treatments. Here, our epigenomic analyses uncovered an enrichment of SP/KLF transcription factors...
9.
Lin G, Yan C, Li L, Qiu X, Zhao Y, Lin J, et al.
Cancer Res
. 2025 Mar;
PMID: 40053469
Immune checkpoint blockade (ICB) therapies have achieved significant breakthroughs in cancer treatment over the past decade. However, ICB is largely ineffective in desert-type gastric cancer (GC) due to intrinsic tumor...
10.
Bergo H, Leak L, Bivona T
Cancer Res
. 2025 Mar;
PMID: 40053457
Therapy resistance is a significant cause of death in patients treated with targeted cancer therapy in diverse oncogene-driven cancers. A better understanding of resistance mechanisms can lay the foundation for...